Search

Search Constraints

You searched for: Author/Creator Tada, T.

Search Results

1. 65P Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: A large real life worldwide population. (December 2022)

2. 67P Real-world data for atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. (December 2022)

7. Incidence and risk factors of esophagogastric varices bleeding in cirrhotic patients with advanced hepatocellular carcinoma treated with lenvatinib. (March 2023)